http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#head http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#assertion http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#provenance http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#assertion http://bio2rdf.org/drugbank:DB00055 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://bio2rdf.org/drugbank:DB01109 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://purl.org/dc/terms/identifier drugbank_resource:DB00055_DB01109 http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://purl.org/dc/terms/title DDI between Drotrecogin alfa and Heparin - The potential benefits of drotrecogin alfa should be weighed against an increased risk of bleeding in patients receiving therapeutic doses of heparin. Monitor for bleeding during concomitant therapy, and immediately stop infusion of drotrecogin if clinically important bleeding occurs. In patients receiving prophylactic heparin doses, consider continuing this during drotrecogin. http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00055_DB01109 http://www.w3.org/2000/01/rdf-schema#label DDI between Drotrecogin alfa and Heparin - The potential benefits of drotrecogin alfa should be weighed against an increased risk of bleeding in patients receiving therapeutic doses of heparin. Monitor for bleeding during concomitant therapy, and immediately stop infusion of drotrecogin if clinically important bleeding occurs. In patients receiving prophylactic heparin doses, consider continuing this during drotrecogin. [drugbank_resource:DB00055_DB01109] http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#provenance http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#signature.MCwCFB0YuZm_jAeX http://purl.org/nanopub/x/hasPublicKey MIIBtzCCASwGByqGSM44BAEwggEfAoGBAP1/U4EddRIpUt9KnC7s5Of2EbdSPO9EAMMeP4C2USZpRV1AIlH7WT2NWPq/xfW6MPbLm1Vs14E7gB00b/JmYLdrmVClpJ+f6AR7ECLCT7up1/63xhv4O1fnxqimFQ8E+4P208UewwI1VBNaFpEy9nXzrith1yrv8iIDGZ3RSAHHAhUAl2BQjxUjC8yykrmCouuEC/BYHPUCgYEA9+GghdabPd7LvKtcNrhXuXmUr7v6OuqC+VdMCz0HgmdRWVeOutRZT+ZxBxCBgLRJFnEj6EwoFhO3zwkyjMim4TwWeotUfI0o4KOuHiuzpnWRbqN/C/ohNWLx+2J6ASQ7zKTxvqhRkImog9/hWuWfBpKLZl6Ae1UlZAFMO/7PSSoDgYQAAoGAETGrDm8R3KfndKRj7ttr3jVhhstI6/2Ey0ER9F5kdx7Hrd6eolq7yWzPzf2H754tdZxICzxYcdawBbL2ZUzFjWwXTNUQC3+e6evKPJyNELubnZcA+8TxIIwicBnw3Ku6mSeI8SUVr5SBV1VeJoSu/ahldv562IdBR8IagmzuT3Y= http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#signature.MCwCFB0YuZm_jAeX http://purl.org/nanopub/x/hasSignature MCwCFB0YuZm/jAeX38IJhsCBX63OLFtlAhQFOYYmCFKFFOzD/jT8+sMRTY9UPg== http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#signature.MCwCFB0YuZm_jAeX http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://purl.org/dc/terms/created 2018-03-30T11:13:05.770+02:00 http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs#signature.MCwCFB0YuZm_jAeX http://bio2rdf.org/drugbank_resource:DB00055_DB01109_nanopub.RA24xdebiLpO7xcX3wUJTAMnlxztQ00HGlR9JzWmwgFIs http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234